ライフサイエンスコーパス: weight reduction

1 support, joint movement, impact protection, weight reduction).

2 ric surgery leads to substantial and durable weight reduction.

3 health improvements associated with moderate weight reduction.

4 ive in rodent models of food intake and body weight reduction.

5 t for suppressing appetite and inducing body weight reduction.

6 ocked the effects of leptin upon satiety and weight reduction.

7 that induced by certain anorexigens used for weight reduction.

8 ically proven mechanisms for pharmacological weight reduction.

9 abdominally obese men at baseline and after weight reduction.

10 to develop and test effective strategies for weight reduction.

11 In some cases, NASH may be reversed with weight reduction.

12 change occurs during the earliest phases of weight reduction.

13 d an increase in circulating vitamin D after weight reduction.

14 oves glycemic control, often with associated weight reduction.

15 eight reduction relative to the overall body weight reduction.

16 n the previously reported normal range after weight reduction.

17 roup) before and after equivalent short-term weight reduction.

18 are likely to benefit most from preoperative weight reduction.

19 PED1) decreases in adipose tissue (AT) after weight reduction.

20 with fewer contact hours showed a benefit in weight reduction.

21 be one mechanism that induces bone loss with weight reduction.

22 erwent bariatric surgery as an instrument of weight reduction.

23 n to attenuate the bone loss associated with weight reduction.

24 ripheral glucose metabolism before and after weight reduction.

25 analysis to low-risk women eliminated birth weight reductions.

26 these interventions resulted in only modest weight reductions.

27 s mutant mice have stunted growth (20 to 50% weight reduction), a high postnatal death rate of 60 to

28 Weight reduction achieved through lifestyle intervention

29 n 24 h food intake in rats, and over 5% body weight reduction after 14-day oral treatment in diet-ind

30 tment resulted in dose-dependent, reversible weight reduction and adipose tissue loss.

31 Whether weight reduction and cardiometabolic risk factor managem

32 lecule degradation as evidenced by molecular weight reduction and change in monomer amount.

33 ores and consequently exhibit both molecular weight reduction and change in Z-numbers.

34 mjd3 transgenic mice show age-dependent body weight reduction and cold intolerance, respectively.

35 We reviewed the psychosocial consequences of weight reduction and concluded that weight loss is usual

36 caffolds and medical implants, to mechanical weight reduction and control over mechanical properties.

37 The Rosa-Lkb1 mice exhibited body weight reduction and died within 6 weeks after tamoxifen

38 Weight reduction and exercise are the mainstays of treat

39 The goals of weight reduction and improving mental and physical healt

40 demonstrated short-term efficacy in inducing weight reduction and in reversing the comorbidities of o

41 ter approach emphasizes lifestyle therapies (weight reduction and increased exercise), which target a

42 The fundamental approach is weight reduction and increased physical activity; howeve

43 to the near-intractable problem of sustained weight reduction and its underlying mechanisms.

44 der adding policies or programs that address weight reduction and maintenance as part of ongoing comp

45 proach is lifestyle intervention, especially weight reduction and physical activity.

46 A program targeting gradual weight reduction and physical exercise continues to be t

47 are frequently associated with inconsistent weight reduction and serious perioperative complications

48 ir usual weight (Wt(initial)) and then after weight reduction and stabilization at 10% below initial

49 Although weight reduction and statin therapy reduce HSCRP levels,

50 tudy was to evaluate the effects of moderate weight reduction and subsequent partial weight regain on

51 s, as in the development of drugs to promote weight reduction and to reduce insulin resistance.

52 The precise role of weight reduction and ursodeoxycholic acid therapy in the

53 e associated renal disease is ameliorated by weight reduction and/or blockade of the renin-angiotensi

54 creased contralateral prostate invasion (46% weight reduction) and lymph node metastasis (50% inhibit

55 The MC4R genotype, postpartum weight reduction, and glycemic changes between after del

56 Few obese people are successful in long-term weight reduction, and thus there is little direct eviden

57 Weight reduction as a way to reduce risk should be inves

58 revealed suppression of food intake and body weight reduction as well as glucose-lowering effects med

59 oup had maintained a clinically important 5% weight reduction at month 12, compared with 29% of patie

60 d of chondroitin sulfate resulted in gel wet weight reduction but not gel destruction.

61 , low-carbohydrate diets are widely used for weight reduction, but they may also have detrimental eff

62 e increases lipolysis, which results in body weight reduction, but this increase also elevates the le

63 an alternative strategy to assist postpartum weight reduction by increasing EPA and DHA status togeth

64 Whether weight reduction can be safely achieved through lifestyl

65 Whether rapid weight reduction can precipitate gallstone formation is

66 ans) and spleen were detected after a 6.2-kg weight reduction compared with a control group.

67 Percent weight reduction correlated significantly with improveme

68 smokers (50.6 years), or were currently on a weight reduction diet (50.5 years).

69 , the use of acetazolamide with a low-sodium weight-reduction diet compared with diet alone resulted

70 Low-sodium weight-reduction diet plus the maximally tolerated dosag

71 d mild visual loss who received a low-sodium weight-reduction diet.

72 effect of smartphone applications (apps) on weight reduction due to the several limitations of previ

73 ater after the main meal may lead to greater weight reduction during a weight-loss program.

74 ight loss; however, a simplified approach to weight reduction emphasizing only increased fiber intake

75 e traveled, fuel-mass coefficient, secondary weight reduction factor, fuel consumption allocation, re

76 very low-calorie diet (890 kcal/d until 15% weight reduction, followed by a weight maintenance diet)

77 c silencing ablates the food intake and body weight reduction following vCA1 GLP-1R activation.

78 able dose, as compared to more than 70% body weight reduction for DNR.

79 least 4.5 kg at 6 months and maintained this weight reduction for the next 30 months had the greatest

80 ts suggest that strategies focusing on small weight reductions for the entire population may be more

81 lls, NAS scores decreased significantly with weight reductions >/=10%.

82 R/shFABP4 led to metabolic recovery and body-weight reduction (>20%).

83 iac disease should not be transplanted until weight reduction has been accomplished.

84 the use of dexfenfluramine hydrochloride for weight reduction has been widely publicized since its ap

85 ay be a simple strategy for promoting modest weight reduction; however, the effectiveness of this str

86 s of body fatness after otherwise successful weight reduction if there were a corresponding reduction

87 initial attempt at blood pressure control by weight reduction, if indicated), and, for cigarette smok

88 Weight reduction improved blood pressure, lipid levels,

89 to the normoglycemic range with significant weight reduction in a high-fat diet (HFD) induced diabet

90 rea, which demonstrated a 68 +/- 7% thrombus weight reduction in an established rat arterial thrombos

91 that caused food intake suppression and body weight reduction in diet-induced obese rats and dogs.

92 A single dose of 10 elicited sustained body weight reduction in DIO rats for at least 21 days.

93 SED showed ~30-59% tumor volume/weight reduction in H1650 tumor model compared to DIM-P

94 Cigarette smoking promotes body weight reduction in humans while paradoxically also prom

95 The role of pretransplantation weight reduction in improving graft and patient outcomes

96 No significant body weight reduction in mice was observed for ADNR at the ma

97 t potent effects on glucose control and body weight reduction in mice, with the dual agonist antibody

98 magnets, allowing for considerable size and weight reduction in modern applications.

99 -risk individuals, controlling pre-diabetes, weight reduction in obese individuals, lowering blood pr

100 vascular disease risk factors in response to weight reduction in obese older women.

101 ate the effectiveness of a smartphone app on weight reduction in obese or overweight individuals, bas

102 s known regarding the effects of substantial weight reduction in obese patients with HF.

103 We aimed to investigate long-term effects of weight reduction in psoriasis.

104 he hindbrain, and liraglutide-dependent body weight reduction in rats was independent of GLP-1 recept

105 However, the recent finding of sustained weight reduction in response to systemic administration

106 longed efficacy for glucose control and body weight reduction in rodents with superior in vitro and i

107 modality in terms of extent and duration of weight reduction in selected patients with acceptable op

108 he clinical utility of an app for successful weight reduction in the majority of the app users; the e

109 a discussion regarding the current state of weight reduction in the prevention and treatment of CV d

110 se were significantly modified by postpartum weight reduction in women who had experienced GDM.

111 ith DSS, COG112 ameliorated the loss of body weight, reduction in colon length, and histologic injury

112 ention was based on 3 lifestyle programs for weight reduction, increasing physical activity, and smok

113 Weight reduction is advocated for overweight people to r

114 e prevention of future hypertension and that weight reduction is an important therapeutic interventio

115 Treatment of NASH is unproven, but weight reduction is recommended in obese patients.

116 While weight reduction is the most commonly practiced treatmen

117 Weight reduction is typically recommended, but efficacy

118 Switching was associated with larger weight reductions (least squares mean=2.9 kg) and a net

119 Although it would seem prudent to recommend weight reduction <30 kg/m2 to all patients before transp

120 Weight reduction may reduce the severity of psoriasis, b

121 h on adiposity prevention and more effective weight reduction methodology are urgently needed.

122 d programs for weight maintenance as well as weight reduction must become a higher public health prio

123 eight (Wt(initial)), a subject maintaining a weight reduction of > or =10% after recent (5-8 wk) comp

124 rsists in persons who have maintained a body-weight reduction of > or =10% for >1 y.

125 ooled analysis showed an overall significant weight reduction of -0.34 kg (95% CI: -0.63, -0.04 kg; P

126 in the POWeR+F group achieved an additional weight reduction of 1.5 kg (95% CI 0.6-2.4; p=0.001) ave

127 A weight reduction of 9.8 N (1 kg) was associated with red

128 ot have a measurable impact on the molecular weight reduction of waxy flour.

129 similar types of studies have reported that weight reductions of as little as 4-5 kg result in norma

130 studies show weak evidence of benefits from weight reduction on asthma outcomes.

131 ttle direct evidence regarding the impact of weight reduction on cancer risk.

132 ion between the MC4R genotype and postpartum weight reduction on changes in fasting plasma glucose (P

133 sical activity, even at moderate levels, and weight reduction on improving insulin sensitivity and re

134 s undergoing PTCA and to study the impact of weight reduction on the long-term survival of obese pati

135 Therefore, we aimed to measure the effect of weight reduction on the severity of psoriasis in obese p

136 ortant determinant of the positive effect of weight reduction on vascular function with hyperinsuline

137 avior modification, with a goal of 7% to 10% weight reduction, on clinical parameters of NASH.

138 However, no body weight reduction or effects on glucose or insulin were o

139 ant but may only affect adult health if such weight reduction persists into adulthood.

140 Weight reduction positively impacts blood pressure.

141 orted the use of performance-enhancement and weight-reduction products, and 22% of soldiers consumed

142 nd 13 normal homozygotes, were admitted to a weight reduction program of 13 +/- 3 months, with weight

143 foods and beverages during 16 wk of a 19-wk weight-reduction program (active weight loss), a 1-y mai

144 ith and without liver steatosis undergoing a weight-reduction program to test whether an effective we

145 ntext of a culturally adapted, comprehensive weight-reduction program.

146 nt children participating in a low-intensity weight-reduction program.

147 icipated in a monthly dietitian-administered weight-reduction program.

148 ly performed surgeries, the amount of excess weight reduction ranges from 49% for laparoscopic adjust

149 Weight reduction reduces bone mineral density (BMD) and

150 had the most significant impact on molecular weight reduction, reducing intrinsic viscosity from 1.75

151 Fasting triacylglycerol in addition to body weight reduction related more to glycemic load than to G

152 The ultimate benefit of weight reduction relates to the reduction of the comorbi

153 ipose tissues underwent much more pronounced weight reduction relative to the overall body weight red

154 e asthma has antiinflammatory effects beyond weight reduction, requires further study.

155 Weight reduction significantly improved physiologic capa

156 uture studies examining the effectiveness of weight reduction strategies in reducing CAC progression

157 kg/mo) were associated with greater initial weight reduction than gastric banding (2.77 kg/mo).

158 ic disease or diabetes rather than as a mere weight-reduction therapy changes demographical and clini

159 to "bariatric surgery," conceived as a mere weight-reduction therapy.

160 icant cholesterol, lipoprotein (a), and body-weight reduction (up to 7% after 1 wk) with no effect on

161 The body weight reduction was due to reduced weight of various ti

162 Mean (SD) body weight reduction was greater with tolvaptan on day 1 (tr

163 Significant amelioration of weight reduction was noted in treated mice.

164 In the present study, to control for weight reductions, we used litters with double the numbe

165 GFR and body weight reduction were correlated.

166 Weight reduction will decrease bone mass and mineral den

167 Weight reduction with daily exercise and limiting intake

168 In this study, weight reduction with intensive risk factor management r

169 e core molecules exhibit primarily molecular weight reduction with no change in the total unsaturatio

170 nea reduction, despite significantly greater weight reduction with tolvaptan (-2.4 +/- 2.1 kg vs. -0.

171 ore people can maintain clinically important weight reductions with a web-based behavioural program a

172 sucrose diet caused profound and sustainable weight reduction without affecting food intake.